General Information of the Compound
Compound ID
CP0373632
Compound Name
2-(3-(piperidin-1-yl)propoxy)-5-(3-(piperidin-1-yl)propyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
    Show/Hide
Synonyms
BDBM50327233
CHEMBL1257934
ST-1093
    Show/Hide
Structure
Formula
C22H38N4OS
Molecular Weight
406.64
Canonical SMILES
C(COc1nc2CCN(CCCN3CCCCC3)Cc2s1)CN1CCCCC1
    Show/Hide
InChI
InChI=1S/C22H38N4OS/c1-3-10-24(11-4-1)14-7-15-26-17-9-20-21(19-26)28-22(23-20)27-18-8-16-25-12-5-2-6-13-25/h1-19H2
    Show/Hide
InChIKey
SYMZYURRALQTPH-UHFFFAOYSA-N
Physicochemical Property
logP
3.632
Rotatable Bonds
9
Heavy Atom Count
28
Polar Areas
31.84
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 52940790
ChEMBL ID
CHEMBL1257934
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 20 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ST-1093 )
Drug Name ST-1093
Target(s)
Histamine H3 receptor (H3R)
Inhibitor